Orexo Licenses Abstral Cancer Drug In China

Sweden-based Orexo and the Chinese pharmaceutical company NovaMed Pharmaceuticals have signed an exclusive licensing and distribution agreement that grants NovaMed rights to seek approval for the marketing and distributing of.....

Subscribe for Full Access!

Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
Subscribe!
Share this Data